Could one drug be enough? new study challenges combo therapy for IBD
NCT ID NCT07564609
First seen May 07, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study compares two treatments for Crohn's disease and ulcerative colitis: using the drug infliximab alone versus infliximab plus another immune-suppressing drug. The goal is to see if the single drug is just as good at keeping patients in remission without steroids. About 420 adults who have already started infliximab will be followed for at least 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Amiens
Amiens, France
-
CHU Besançon
Besançon, France
-
CHU Clermont Ferrand
Clermont-Ferrand, 63000, France
-
CHU Dijon
Dijon, France
-
CHU Grenoble
Grenoble, France
-
CHU Lille
Lille, France
-
CHU Monptellier
Montpellier, France
-
CHU Nancy
Nancy, France
-
CHU Nantes
Nantes, France
-
CHU Nîmes
Nîmes, France
-
CHU Rouen
Rouen, France
-
CHU Toulouse
Toulouse, France
-
Hospice Civil de Lyon
Lyon, France
-
Hôpital Beaujon AP-HP
Clichy, France
-
Hôpital Bicêtre AP-HP
Le Kremlin-Bicêtre, France
-
Hôpital Henri-Mondor AP-HP
Créteil, France
-
Hôpital Henri-Mondor AP-HP
Marseille, France
-
Institut des MICI
Neuilly-sur-Seine, France
Conditions
Explore the condition pages connected to this study.